AKT1 and B-cell acute lymphoblastic leukemia: USP1 deubiquitinates AKT in vivo and cuts the ubiquitin chain at the Lys63 site of AKT, thus inhibiting PI3K-Akt signal transduction in B-cell acute lymphoblastic leukemia [185].